Literature DB >> 11912373

A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis.

Joan H Parks1, Evan Goldfisher, John R Asplin, Fredric L Coe.   

Abstract

PURPOSE: We determined the adequacy of a single 24-hour urine sample for evaluating patients for medical renal stone prevention.
MATERIALS AND METHODS: A total of 459 patients from a private urology practice specializing in the treatment of urolithiasis and 683 from a university stone research clinic provided 2 and 3, 24-hour urine samples, respectively. We used samples 1 and 2 from private practice patients, and 1 and 3 from university clinic patients for analysis, and compared each to the others by correlation coefficients and calculation of the mean difference plus or minus standard deviation (SD) of the difference. Urine risk factors were measured by standard methods.
RESULTS: Although the correlation of urine values 1 and 2 was excellent for all stone risk factors, SD values for the differences were large enough that within 1 SD on either side of 0, which included 68.8% of cases, by chance urine 1 would depart from urine 2 by clinically important amounts. These departures would be more than sufficient to misdiagnose common metabolic disorders.
CONCLUSIONS: A single 24-hour sample is not sufficient for evaluating patients before metabolic treatment for stone prevention because misdiagnosis is common, leading to inappropriate treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11912373

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  46 in total

1.  Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic.

Authors:  Madhur Nayan; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

2.  Stones. A matter of doubt--how best to evaluate stone formers.

Authors:  Fredric L Coe
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

3.  Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Carrie L Philips; Fredric L Coe
Journal:  Kidney Int       Date:  2010-04-28       Impact factor: 10.612

4.  Arguments for a comprehensive metabolic evaluation of the first-time stone former.

Authors:  Ryan F Paterson
Journal:  Can Urol Assoc J       Date:  2010-06       Impact factor: 1.862

5.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

Review 6.  The use of risk indices: do they predict recurrence? Yes, they (at least some) do.

Authors:  Norbert Laube; Michael Pullmann
Journal:  Urol Res       Date:  2006-01-06

Review 7.  Management of kidney stones.

Authors:  Nicole L Miller; James E Lingeman
Journal:  BMJ       Date:  2007-03-03

8.  Medical evaluation and management of urolithiasis.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Ther Adv Urol       Date:  2010-02

9.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

Review 10.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.